Schizophrenia Trials in Samara, Russia
Conditions / Schizophrenia / Samara, Russia
Schizophrenia is a medical condition with active clinical research programs worldwide.
31 total trials for this combination
Showing top 10 of 31 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02970305 | Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE) | COMPLETED | PHASE2 |
| NCT01397786 | Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia | COMPLETED | PHASE3 |
| NCT01192867 | A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310) | COMPLETED | PHASE3 |
| NCT02970292 | Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1) | COMPLETED | PHASE3 |
| NCT01235520 | A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307) | COMPLETED | PHASE3 |
| NCT01129674 | A Long-Term, Open-Label, Study on Schizophrenia | TERMINATED | PHASE2/PHASE3 |
| NCT03201757 | Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 | COMPLETED | PHASE3 |
| NCT03187769 | Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder | COMPLETED | PHASE3 |
| NCT01716975 | Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy | COMPLETED | PHASE3 |
| NCT00590577 | Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia | COMPLETED | PHASE3 |